21216 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen; Proteins Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
METHODS FOR IMPROVING FILTERABILITY OF POLYSACCHARIDE-PROTEIN CONJUGATE REACTIONS
#302Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
#303compositions and methods thereof
#304Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
#305PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
#306Conjugated vaccine carrier proteins
#307Enhancing immunogenicity of polysaccharide-protein conjugates
#308Method for producing Hib conjugate vaccine using PRP with lowered molecular weight
#309Methods for making polysaccharide-protein conjugates
#310capsule polysaccharide vaccines
#311Synthetic vaccines against serotype 2
#312IL-23-P19 VACCINES
#313IMMUNOGENIC COMPOSITION
#314Immunotherapeutic compositions for the treatment of Alzheimer's disease
#315Semi-synthetic meningococcal conjugate vaccine
#316Process for preparing pneumococcal polysaccharide-protein conjugates
#317Antibodies that modulate immunity to drug resistant and latent MTB infections
#318METHOD OF OPTIMIZING PEPTIDE IMMUNO-EPITOPE BY GLYCOSYLATION, OPTIMIZED PEPTIDE THEREOF AND ITS USE FOR CONJUGATE VACCINES
#319Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
#320Pneumococcal dosing regimen
#321Immunogenic compositions for use in pneumococcal vaccines
#322Immunogenic composition against
#323Vaccines targeting
#324Glycoconjugation process
#325Cholera toxin chimera and its use as a staph vaccine
#326Immunogenic composition
#327Precision glycoconjugates as therapeutic tools
#328Peptide vaccines against interleukin-31
#329Vaccine
#330Pneumococcal polysaccharide-protein conjugate composition
#331Multivalent pneumococcal conjugate vaccine
#332ANTI-OPIOID VACCINES
#333Influenza mucosal vaccine composition and preparation and application thereof
#334Multivalent glycoconjugate vaccines
#335Multivalent glycoconjugate vaccines
#336Nanovesicle derived from genus bacteria, and use thereof
#337Codon optimization for increasing transgene expression in chloroplasts of higher seed plants
#338Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#339vaccine
#340Antibodies targeted to fungal cell wall polysaccharides
#341type 5 capsular saccharides
#342MHC Class I Epitope Delivering Polypeptides
#343Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#344Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
#345Compositions comprising angiogenic factors and methods of use thereof
#346ExPEC glycoconjugate vaccine formulations
#347PcrV-linked antigen vaccines
#348Adhesin tip multiepitope fusion antigen platform and vaccines and their use in the treatment of enterotoxigenic diarrhea
#349Method for vaccination against a self-antigen in a human patient
#350Production of recombinant vaccine in by enzymatic conjugation
#351STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
#352Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
#353Multivalent meningococcal polysaccharide-protein conjugate vaccine
#354Meningococcus serogroup X conjugate
#355RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF USING THE SAME IN CANCER IMMUNOTHERAPY
#356Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
#357Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
#358Combined enteropathogen recombinant construct
#359Thermally stable rotavirus vaccine formulations and methods of use thereof
#360capsular polysaccharides and conjugates thereof
#361Immunogenic compositions for use in pneumococcal vaccines
#362Bordetella pertussis immunogenic vaccine compositions
#363Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
#364Manufacture of vaccines and compositions for the prevention of infections
#365Vaccines and compositions for the prevention of infections
#366Immunogenic proteins against clostridium difficile
#367Methods for the prevention of infections
#368Methods for making saccharide-protein glycoconjugates
#369Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#370Polypeptide-antigen conjugates with non-natural amino acids
#371COMBINATION VACCINES WITH SEROGROUP B MENINGOCOCCUS AND D/T/P
#372Vaccines against serotype 5
#373Method for improving the efficacy of a survivin vaccine in the treatment of cancer
#374Anti-cancer vaccine combination
#375Cholera toxin chimera and its use as a staph vaccine
#376Immunogenic compositions against
#377Immunogenic composition against
#378Multivalent pneumococcal polysaccharide-protein conjugate composition
#379Universal cancer vaccine
#380Antibodies targeted to fungal cell wall polysaccharides
#381Process for preparing pneumococcal polysaccharide-protein conjugates
#382VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES
#383Compositions against cat allergy
#384Methods of treating and preventing influenza infections
#385Injectable vaccines against multiple meningococcal serogroups
#386Methods and compositions for immune protection against extra-intestinal pathogenic
#387Glycoconjugation processes and compositions
#388Carrier molecule compositions and related methods
#389Pneumococcal capsular saccharide conjugate vaccine
#390Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides
#391Synthetic antigen constructs against
#392Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#393Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof
#394DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#395Multivalent meningococcal polysaccharide-protein conjugate vaccine
#396Conjugation of type 5 and type 8 capsular polysaccharides
#397IMMUNOGENIC AND VACCINE COMPOSITIONS FOR USE AGAINST BORDETELLA BRONCHISEPTICA INFECTION
#398Antibodies that modulate immunity to drug resistant and latent MTB infections
#399Immunogenic compositions and uses thereof
#400Fusion polypeptide for immuno-enhancement and method for enhancing stimulation of immune response using the same
#401ExPEC glycoconjugate vaccine formulations
#402IL-23-p19 vaccines
#403Immunogenic composition
#404IMMUNOGENIC COMPOSITION
#405IMMUNOGENIC COMPOSITION FOR USE IN THERAPY
#406Methods to improve induction of IgA antibodies by vaccines
#407Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#408Compositions and methods for producing bacterial conjugate vaccines
#409Vaccines against carbapenem-resistant
#410Immunogenic polypeptides
#411Immunogenic composition
#412Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
#413Glycoconjugate vaccine for
#414Probiotics, secretory IgA and inflammation
#415IMMUNOGENIC COMPOSITIONS
#416Cholera toxin chimera and its use as a staph vaccine
#417METHOD FOR PROLONGING AND ENHANCING ANTI-TUMOR VACCINE RESPONSE
#418COMPOSITIONS AND METHODS FOR THERAPEUTIC ANTI-CANCER VACCINATION
#419Immunogenic/therapeutic glycan compositions and uses thereof
#420Method for rapid in vitro synthesis of glycoproteins via recombinant production of -glycosylated proteins in prokaryotic cell lysates
#421Lipid A mimics, methods of preparation, and uses thereof
#422Polypeptides and antibodies for treating HBV infection and related diseases
#423compositions and methods thereof
#424METHOD FOR AMELIORATING AND ABATING SYMPTOMS RESULTING FROM RHEUMATOID ARTHRITIS, FIBROMYALGIA, AND CHRONIC PAIN OF UNKNOWN ORIGIN
#425Polysaccharide and uses thereof
#426Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
#427Method for Producing and Vaccine Composition of Neisseria Meningitidis Serogroups A, C, Y, and W-135 Oligosaccharides Conjugated to Glycan-Free Carrier Protein
#428Modified virus-like particles of CMV
#429LPS vaccine
#430METHOD OF TREATMENT
#431Glycan conjugates and use thereof
#432Combined enteropathogen recombinant construct
#433Pneumococcal dosing regimen
#434Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereof
#435Conjugation of capsular saccharides
#436RECOMBINANT LISTERIA STRAIN EXPRESSING HETEROLOGOUS ANTIGEN FUSION PROTEINS AND METHODS OF USE THEREOF
#437Vaccines against serotype 8
#438Polyvalent pneumococcal polysaccharide-protein conjugate composition
#439Glycoconjugation processes and compositions
#440Method for producing type B antigens
#441Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#442NOVEL SEMI-SYNTHETIC MENINGOCOCCAL CONJUGATE VACCINE
#443Glycoconjugate vaccines
#444Composite antigenic sequences and vaccines
#445Compositions and methods of enhancing immunogenicity of polysaccharide protein conjugates
#446METHOD FOR PRODUCING AND VACCINE COMPOSITION OF NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y, AND W-135 OLIGOSACCHARIDES CONJUGATED TO GLYCAN-FREE CARRIER PROTEIN
#447Multivalent glycoconjugate vaccines
#448Chimeric vaccine against fungal infections
#449Capsular gram-positive bacteria bioconjugate vaccines
#450Methods of host cell modification
#451Vaccine composition and uses thereof
#452Cellular vaccine and method of inducing an immune response in a subject
#453Immunotherapeutic compositions for the treatment of alzheimer's disease
#454COMBINATION VACCINES WITH SEROGROUP B MENINGOCOCCUS AND D/T/P
#455METHODS AND COMPOSITIONS FOR INCREASING A T-EFFECTOR CELL TO REGULATORY T CELL RATIO
#456Vaccine compositions comprising a saponin adjuvant
#457Immunogenic composition
#458Oligosialic acid derivatives, methods of manufacture, and immunological uses
#459Compositions comprising angiogenic factors and methods of use thereof
#460Capsular polysaccharide solubilisation and combination vaccines
#461COMPOSITIONS HAVING MEANS FOR TARGETING AT LEAST ONE ANTIGEN TO DENDRITIC CELLS
#462MODIFIED HOST CELLS AND USES THEREOF
#463Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
#464Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof
#465Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof
#466Monoclonal antibodies that modulate immunity to MTB and enhance immune clearance
#467Immunogenic glycoprotein conjugates
#468Vaccine compositions and methods for restoring NKG2D pathway function against cancers
#469PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES
#470Vectors for molecule delivery to CD11b expressing cells
#471Multivalent pneumococcal polysaccharide-protein conjugate composition
#472Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
#473Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof
#474Immunogenic compositions and methods
#475Recombinant vaccine strains and methods of using the same in cancer immunotherapy
#476Injectable vaccines against multiple meningococcal serogroups
#477Synthetic vaccines against type 1
#478Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#479capsular polysaccharides and conjugates thereof
#480Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea
#481immunogenic vaccine compositions
#482Integration of meningococcal conjugate vaccination
#483Prevention of infections by glycoprotein vaccines synthesized in
#484Methods for making saccharide-protein glycoconjugates
#485Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
#486Method of treatment
#487Salmonella conjugate vaccines
#488Vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific T-cell responses
#489Vaccine comprising capsular polysaccharide conjugates
#490Process for stabilizing an adjuvant containing vaccine composition
#491Glycan conjugates and methods of use thereof
#492EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF
#493Bacterial vaccine and methods for manufacture thereof
#494Compositions comprising angiogenic factors and methods of use thereof
#495RM2 antigens and use thereof
#496DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#497Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#498Glycan conjugates and use thereof
#499Process for preparing pneumococcal polysaccharide-protein conjugates
#500Universal influenza vaccine
#501Synthetic antigen constructs against
#502GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES
#503CONJUGATED VACCINE
#504Protein matrix vaccines and related methods of making and administering such vaccines
#505Polysaccharide-protein conjugate vaccines
#506Chimeras of lumazine synthase and beta subunit of ABtoxins
#507LOS-derived oligosaccharide with pertussis toxin glycoconjugate and its application in the prophylaxis and treatment of infections caused by
#508Immunization to protect against adverse cardiac events relating to pneumococcal infection
#509Media elaborated with newly synthesized antibodies (MENSA) and uses thereof
#510Method for improving the efficacy of a survivin vaccine in the treatment of cancer
#511OMV vaccines
#512Purification of polysaccharide protein conjugates
#513Conjugation of type 8 capsular polysaccharides
#514Compositions and methods for preparing serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
#515Siderophore-based immunization against gram-negative bacteria
#516ANTIBODIES TARGETED TO FUNGAL CELL WALL POLYSACCHARIDES
#517Immunogenic fusion polypeptides
#518HER2/Neu cancer vaccine
#519METHOD FOR TREATING A beta-AMYLOIDOSIS
#520Multivalent meningococcal polysaccharide-protein conjugate vaccine
#521Glycoconjugation process
#522Glycoconjugate vaccines
#523Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
#524Purification of type 8 capsular saccharides
#525Prion epitopes and methods of use thereof
#526METHOD FOR TREATING A SYNUCLEIOPATHY
#527lipopolysaccharide outer core epitope
#528Immunogenic composition against
#529Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#530Pneumoccal polysacchride conjugate vaccine
#531Polypeptides and antibodies for treating HBV infection and related diseases
#532BIOCONJUGATES COMPRISING MODIFIED ANTIGENS AND USES THEREOF
#533Polysaccharide and uses thereof
#534Conjugation of streptococcal capsular saccharides
#535Immunogenic composition
#536Immunogenic compositions
#537Cellular vaccine and method of inducing an immune response in a subject
#538Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#539Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#540Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
#541Polyvalent pneumococcal polysaccharide-protein conjugate composition
#542Combination vaccines with serogroup B meningococcus and D/T/P
#543Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen
#544Multivalent meningococcal polysaccharide-protein conjugate vaccine
#545Method for producing type B antigens
#546Flagellin fusion proteins
#547Immunogenic compounds comprising HIV GP41 peptide coupled to CRM197 carrier protein
#548Immunogenic compositions of antigens
#549Vaccine and uses thereof
#550Highly immunogenic peptides derived from the human immunodeficiency virus V2 region
#551IgE CH3 peptide vaccine
#552Meningococcus serogroup X conjugate
#553Compositions and methods for the diagnosis and treatment of tumor
#554COMPOSITION
#555COMPOSITIONS
#556Vaccine
#557Compositions comprising angiogenic factors and methods of use thereof
#558Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#559PROCESS FOR THE PREPARATION AND USE OF A BIVALENT VACCINE AGAINST MORPHINE-HEROIN ADDICTION
#560Enhancing immunity to tuberculosis
#561Live recombinant booster vaccine against tuberculosis
#562Universal carrier for targeting molecules to GB3 receptor expressing cells
#563Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#564Immunogenic composition
#565Mucosal immunization to prevent prion infection
#566Multivalent pneumococcal polysaccharide-protein conjugate composition
#567Polyanionic polymer adjuvants for Haemophilus influenzae B saccharide vaccines
#568Conjugating amines
#569Immunogenic compositions and methods
#570Capsular gram-positive bacteria bioconjugate vaccines
#571Liquid vaccines for multiple meningococcal serogroups
#572Prion disease-specific epitopes and methods of use thereof
#573Immunogenic composition
#574Porcine circovirus type-2 (PCV2) subunit vaccine
#575Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
#576Method of detecting the presence of an antibody in a sample
#577Methods for making saccharide-protein glycoconjugates
#578Recombinant poxvirus vector comprising tetanus toxin fragment C
#579Pneumococcal dosing regimen
#580Polysaccharide-protein conjugate vaccines
#581Multivalent pneumococcal polysaccharide-protein conjugate composition
#582Multivalent meningococcal polysaccharide-protein conjugate vaccine
#583Vaccine for
#584Compositions and methods for activating innate and allergic immunity
#585Hypo- and hyper-acetylated meningococcal capsular saccharides
#586Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
#587Immunogenic compositions against human progastrin peptides
#588Algal produced malarial transmission blocking vaccines
#589Protein matrix vaccines and methods of making and administering such vaccines
#590Conjugation process of bacterial polysaccharides to carrier proteins
#591Conjugation process of bacterial polysaccharides to carrier proteins
#592Glycoconjugates and their use as potential vaccines against infection by
#593Methods of improving vaccine immunogenicity
#594Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof
#595Immunogenic composition
#596Pneumococcal vaccine and uses thereof
#597Protein matrix vaccine compositions including polycations
#598Targeting poly-gamma-glutamic acid to treat and related infections
#599Methods for preparing complex multivalent immunogenic conjugates
#600CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses